Please use this identifier to cite or link to this item: http://localhost:80/xmlui/handle/123456789/14160
Full metadata record
DC FieldValueLanguage
dc.contributor.authorA. KHAN, SEHER-
dc.date.accessioned2022-11-29T05:03:22Z-
dc.date.available2022-11-29T05:03:22Z-
dc.date.issued2009-07-20-
dc.identifier.citationKhan, S. A. (2009). The role of pomegranate (Punica granatum L.) in colon cancer. Pakistan journal of pharmaceutical sciences, 22(3).en_US
dc.identifier.issn1011-601X-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/14160-
dc.description.abstractColon cancer is one of the major causes of cancer-related death in the Western world. Although cytotoxic chemotherapeutic agents are available to treat the disease, these agents become ineffective as the disease advances to an invasive state. An alternative but viable approach to reduce the incidence of this deadly disease is then, to increase the dietary intake of relatively non-toxic fruits and vegetables. An example of a fruit with antioxidant, antidiabetic and anti-atherosclerotic properties is pomegranate. Pomegranate produces anticancer effects in experimental models of lung, prostate and skin cancer. More recently, pomegranate has been found to be anti-carcinogenic in the colon. This communication discusses pomegranate’s effect in colon cancer.en_US
dc.language.isoenen_US
dc.publisherKarachi: Faculty of Pharmacy & Pharmaceutical Sciences, Karachien_US
dc.subjectColonen_US
dc.subjectcanceren_US
dc.subjectpomegranateen_US
dc.subjectpreventionen_US
dc.subjectapoptosisen_US
dc.titleTHE ROLE OF POMEGRANATE (PUNICA GRANATUM L.) IN COLON CANCERen_US
dc.typeArticleen_US
Appears in Collections:Issue 03

Files in This Item:
File Description SizeFormat 
Paper-20.htm143 BHTMLView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.